Mona Anandbhai Desai, a promoter of Anupam Rasayan India Limited, has submitted a revised disclosure regarding the encumbrance of shares. This update clarifies details concerning debenture holders and lenders, correcting inadvertent errors from a previous filing. The revised information aligns with system-generated disclosures from depositories, enhancing transparency around the promoter’s holdings.
Revised Disclosure on Share Encumbrance
Mona Anandbhai Desai, a promoter of Anupam Rasayan India Limited (the “Company”), has submitted a revised disclosure concerning the encumbrance of her shares. This revision is in response to an email from BSE Limited dated November 02, 2026, which followed an initial disclosure on October 05, 2026.
Key Clarifications and Corrections
The initial disclosure had identified the trustee for encumbered shares but not the relevant lender(s). The revised filing, as requested by BSE Limited, now clearly identifies both the trustee and the lender(s) for whose benefit the encumbrance has been created. This updated information is provided in Annexure I and Annexure II of the disclosure.
Furthermore, the promoter has corrected inadvertent errors in the previous disclosure. Notably, the name of the issuer has been corrected to Purebliss Pharma Solutions Private Limited, replacing the previously stated Mates Visa Consultancy Private Limited. The revised contents of Annexure I and Annexure II are now aligned with the system-driven disclosures generated by depositories.
Details of Encumbrances
The disclosure details two primary instances of encumbrance:
- On September 23, 2026, 14,60,625 shares (1.28% of share capital) were pledged as security for the payment and discharge of debt arising from non-convertible debentures issued by Purebliss Pharma Solutions Private Limited. The benefit is for the debenture holders, with Catalyst Trusteeship Limited acting as the trustee.
- On September 30, 2026, 25,80,000 shares (2.27% of share capital) were also pledged for similar reasons related to non-convertible debentures issued by Purebliss Pharma Solutions Private Limited. Catalyst Trusteeship Limited serves as the trustee for these debenture holders as well.
The document also provides detailed lists of debenture holders for each encumbrance event, including the number of debentures held by various entities such as GSS India Opportunities AIF, Emerging India Credit Opportunities Fund II, and Aditya Birla Capital Limited.
Source: BSE
